Ciudad de la Habana, Cuba

Gryssell María Rodríguez Martínez


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gryssell María Rodríguez Martínez: Innovator in Cancer Vaccine Development

Introduction: Gryssell María Rodríguez Martínez is a notable inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the biotechnology sector, particularly in human healthcare. His work focuses on developing innovative solutions for cancer treatment, showcasing his dedication to improving patient outcomes.

Latest Patents: Gryssell holds a patent for a homogeneous vaccine composition comprising a conjugate of Epidermic Growth Factor (EGF) and P64K for the treatment of tumors. This invention addresses a critical need in cancer therapy by providing a vaccine composition designed for therapeutic use in cancer patients. The active principle of this composition is a chemical conjugate of human recombining Epidermic Growth Factor (hrEGF) and the protein P64K. The patent outlines specific conditions for performing a conjugation reaction, ensuring that the chemical conjugate is produced in a controlled and reproducible manner. Additionally, the invention includes a method for purifying the chemical conjugate, which enhances the purity of the therapeutic composition and surprisingly increases its immunogenic activity. This results in significant increases in anti-EGF antibody titers in humans. The versatility of the vaccine preparation allows for multiple dose presentations, enabling increased immunization doses without raising the frequency or number of immunization sites.

Career Highlights: Gryssell is affiliated with the Centro de Inmunología Molecular (CIM), where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of cancer immunotherapy, contributing to the ongoing fight against this devastating disease.

Collaborations: Gryssell has collaborated with talented colleagues, including Lisel Viña Rodríguez and Loany Calvo González. Their combined expertise enhances the research and development efforts at CIM, fostering innovation in cancer treatment.

Conclusion: Gryssell María Rodríguez Martínez exemplifies the spirit of innovation in the biotechnology sector, particularly in the development of cancer vaccines. His contributions are paving the way for more effective therapeutic options for cancer patients, highlighting the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…